Clinical Trial Update: Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of rosuvastatin on coronary flow reserve in hypertensive patients at cardiovascular risk has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Hypertension | Phase 4 | Status: COMPLETED